Blair Williams Todt - 03 Jan 2023 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
EVP and Chief Legal Officer
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol
ELV
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
05 Jan 2023, 16:03:57 UTC
Previous filing
05 Dec 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Award $0 +3,983 +93% $0.000000 8,283 03 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted share units. Restrictions lapse as follows: 1,327 shares on 1/3/2024, and 1,328 shares each on 1/3/2025 and 1/3/2026.